140 related articles for article (PubMed ID: 3346878)
1. 8-Aryl-and 8-cycloalkyl-1,3-dipropylxanthines: further potent and selective antagonists for A1-adenosine receptors.
Shamim MT; Ukena D; Padgett WL; Hong O; Daly JW
J Med Chem; 1988 Mar; 31(3):613-7. PubMed ID: 3346878
[TBL] [Abstract][Full Text] [Related]
2. Structure-activity relationships of 8-cycloalkyl-1,3-dipropylxanthines as antagonists of adenosine receptors.
Katsushima T; Nieves L; Wells JN
J Med Chem; 1990 Jul; 33(7):1906-10. PubMed ID: 1694546
[TBL] [Abstract][Full Text] [Related]
3. Effects of 8-phenyl and 8-cycloalkyl substituents on the activity of mono-, di-, and trisubstituted alkylxanthines with substitution at the 1-, 3-, and 7-positions.
Shamim MT; Ukena D; Padgett WL; Daly JW
J Med Chem; 1989 Jun; 32(6):1231-7. PubMed ID: 2724296
[TBL] [Abstract][Full Text] [Related]
4. 8-Polycycloalkyl-1,3-dipropylxanthines as potent and selective antagonists for A1-adenosine receptors.
Shimada J; Suzuki F; Nonaka H; Ishii A
J Med Chem; 1992 Mar; 35(5):924-30. PubMed ID: 1548682
[TBL] [Abstract][Full Text] [Related]
5. Sulfur-containing 1,3-dialkylxanthine derivatives as selective antagonists at A1-adenosine receptors.
Jacobson KA; Kiriasis L; Barone S; Bradbury BJ; Kammula U; Campagne JM; Secunda S; Daly JW; Neumeyer JL; Pfleiderer W
J Med Chem; 1989 Aug; 32(8):1873-9. PubMed ID: 2754711
[TBL] [Abstract][Full Text] [Related]
6. Analogues of 1,3-dipropyl-8-phenylxanthine: enhancement of selectivity at A1-adenosine receptors by aryl substituents.
Daly JW; Padgett WL; Shamim MT
J Med Chem; 1986 Aug; 29(8):1520-4. PubMed ID: 3016270
[TBL] [Abstract][Full Text] [Related]
7. Species differences in structure-activity relationships of adenosine agonists and xanthine antagonists at brain A1 adenosine receptors.
Ukena D; Jacobson KA; Padgett WL; Ayala C; Shamim MT; Kirk KL; Olsson RO; Daly JW
FEBS Lett; 1986 Dec; 209(1):122-8. PubMed ID: 3803571
[TBL] [Abstract][Full Text] [Related]
8. Trifunctional agents as a design strategy for tailoring ligand properties: irreversible inhibitors of A1 adenosine receptors.
Boring DL; Ji XD; Zimmet J; Taylor KE; Stiles GL; Jacobson KA
Bioconjug Chem; 1991; 2(2):77-88. PubMed ID: 1868116
[TBL] [Abstract][Full Text] [Related]
9. Adenosine receptors: development of selective agonists and antagonists.
Daly JW; Jacobson KA; Ukena D
Prog Clin Biol Res; 1987; 230():41-63. PubMed ID: 3588607
[TBL] [Abstract][Full Text] [Related]
10. Structure-activity relationships of 8-styrylxanthines as A2-selective adenosine antagonists.
Jacobson KA; Gallo-Rodriguez C; Melman N; Fischer B; Maillard M; van Bergen A; van Galen PJ; Karton Y
J Med Chem; 1993 May; 36(10):1333-42. PubMed ID: 8496902
[TBL] [Abstract][Full Text] [Related]
11. Potent adenosine receptor antagonists that are selective for the A1 receptor subtype.
Martinson EA; Johnson RA; Wells JN
Mol Pharmacol; 1987 Mar; 31(3):247-52. PubMed ID: 3561384
[TBL] [Abstract][Full Text] [Related]
12. 7-Deaza-2-phenyladenines: structure-activity relationships of potent A1 selective adenosine receptor antagonists.
Müller CE; Hide I; Daly JW; Rothenhäusler K; Eger K
J Med Chem; 1990 Oct; 33(10):2822-8. PubMed ID: 2213835
[TBL] [Abstract][Full Text] [Related]
13. Mapping the xanthine C8-region of the adenosine A1 receptor with computer graphics.
Van der Wenden EM; Van Galen PJ; IJzerman AP; Soudijn W
Eur J Pharmacol; 1991 Apr; 206(4):315-23. PubMed ID: 1915591
[TBL] [Abstract][Full Text] [Related]
14. Xanthine functionalized congeners as potent ligands at A2-adenosine receptors.
Jacobson KA; Ukena D; Padgett W; Daly JW; Kirk KL
J Med Chem; 1987 Jan; 30(1):211-4. PubMed ID: 3806597
[TBL] [Abstract][Full Text] [Related]
15. 8-Azaxanthine derivatives as antagonists of adenosine receptors.
Franchetti P; Messini L; Cappellacci L; Grifantini M; Lucacchini A; Martini C; Senatore G
J Med Chem; 1994 Sep; 37(18):2970-5. PubMed ID: 8071944
[TBL] [Abstract][Full Text] [Related]
16. Structure-activity relationships of 1,3-dialkylxanthine derivatives at rat A3 adenosine receptors.
Kim HO; Ji XD; Melman N; Olah ME; Stiles GL; Jacobson KA
J Med Chem; 1994 Sep; 37(20):3373-82. PubMed ID: 7932565
[TBL] [Abstract][Full Text] [Related]
17. 8-Substituted xanthines as antagonists at A1- and A2-adenosine receptors.
Jacobson KA; de la Cruz R; Schulick R; Kiriasis L; Padgett W; Pfleiderer W; Kirk KL; Neumeyer JL; Daly JW
Biochem Pharmacol; 1988 Oct; 37(19):3653-61. PubMed ID: 3178879
[TBL] [Abstract][Full Text] [Related]
18. Xanthines with C8 chiral substituents as potent and selective adenosine A1 antagonists.
Peet NP; Lentz NL; Dudley MW; Ogden AM; McCarty DR; Racke MM
J Med Chem; 1993 Dec; 36(25):4015-20. PubMed ID: 8258823
[TBL] [Abstract][Full Text] [Related]
19. Adenosine A1 antagonists. 3. Structure-activity relationships on amelioration against scopolamine- or N6-((R)-phenylisopropyl)adenosine-induced cognitive disturbance.
Suzuki F; Shimada J; Shiozaki S; Ichikawa S; Ishii A; Nakamura J; Nonaka H; Kobayashi H; Fuse E
J Med Chem; 1993 Aug; 36(17):2508-18. PubMed ID: 8355252
[TBL] [Abstract][Full Text] [Related]
20. 1,3,8-trisubstituted xanthines. Effects of substitution pattern upon adenosine receptor A1/A2 affinity.
Erickson RH; Hiner RN; Feeney SW; Blake PR; Rzeszotarski WJ; Hicks RP; Costello DG; Abreu ME
J Med Chem; 1991 Apr; 34(4):1431-5. PubMed ID: 2016719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
